article thumbnail

ARS Pharmaceuticals Snags $55M In Series D Funding

socalTECH

San Diego-based "ARS Pharmaceuticals, which is developing an epinephrine nasal spray designed to better treat severe allergic reaction, said today that it has raised $55M in a Series D funding. The funding was led by SR One, and also included RA Capital Management, an un-named US healthcare-focused fund, and Deerfield Management.

Funding 113
article thumbnail

Capillary Biomedical Gets $1.5M For Insulin Infusion

socalTECH

in loan funding. The company said the funding came in the form of a loan from The Leona M. According to the company, the new funds will go towards clinical studies of its technology, to evaluate the potential for extended-wear of insulin infusion sets by people with Type 1 diabetes for 7 days and beyond. and Harry B.

Study 124
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Five Area Firms Get DOE Funds for Concentrating Solar Power Research

socalTECH

Five, Southern California firms are among companies who are splitting up $62M in government funding for the research, development, and demonstration of concentrating solar power systems, according to an announcement by the U.S. for building a solar power tower plant design; San Diego-based General Atomics getting up to $2.1M

article thumbnail

Why you should never have a data room — the most counter-intuitive fund-raising advice you’ll ever…

Both Sides of the Table

the most counter-intuitive fund-raising advice you’ll ever get I’m about to offer you some fund-raising advice that flies directly in the face of what most conventional wisdom will tell you. Let me start out with my premise: “Data rooms are where fund-raising processes go to die.” I mean, in a real fund-raising process?

Funding 336
article thumbnail

Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests

Xconomy

The cash tops off a Series B round of funding announced last year. The Boston company, which counts diabetes drug giants Eli Lilly (NYSE: LLY ) and Novo Nordisk (NYSE: NVO ) among its investors and partners, says the capital will support Phase 3 studies of its device this year, and if all goes well, an application for FDA approval.

Study 87
article thumbnail

Startups Weekly: VCs are drunk on beverage startups

TechCrunch LA

Liquid Death has attracted nearly $2 million in funding from angel investors like Away co-founder Jen Rubio and Twitter co-founder Biz Stone. For one, because millennials, according to various studies, are consuming less alcohol than previous generations and are therefore seeking non-alcoholic beverage alternatives. . IPO Corner.

Startup 223
article thumbnail

March Capital Partners' Jim Armstrong On A New, $240M Venture Fund

socalTECH

Santa Monica-based March Capital Partners (www.marchcp.com) has just announced a brand new, $240M venture investment fund, led by longtime venture investing veterans Jim Armstrong, Sumant Mandal, Gregory Milken and Jamie Montgomery. What is the investment focus for this fund? All of that represents opportunity, as well.